Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,807 | -3,994 | -2,581 | -10,754 |
| Depreciation Amortization | 541 | 362 | 181 | 751 |
| Accounts receivable | -65 | 284 | 245 | N/A |
| Accounts payable and accrued liabilities | 447 | 226 | 789 | N/A |
| Other Working Capital | 1,434 | 903 | 1,409 | 2,532 |
| Other Operating Activity | 1,390 | 831 | -480 | 2,131 |
| Operating Cash Flow | $-2,062 | $-1,388 | $-437 | $-5,340 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -25 | -13 | -5 | -176 |
| Net Acquisitions | N/A | N/A | N/A | 250 |
| Other Investing Activity | 0 | 0 | 0 | 12 |
| Investing Cash Flow | $-25 | $-13 | $-5 | $86 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,265 | 1,265 | N/A | N/A |
| Other Financing Activity | 1,903 | 80 | 80 | 4,469 |
| Financing Cash Flow | $3,168 | $1,345 | $80 | $4,469 |
| Beginning Cash Position | 469 | 469 | 469 | 1,255 |
| End Cash Position | 1,550 | 414 | 107 | 469 |
| Net Cash Flow | $1,081 | $-56 | $-363 | $-785 |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,062 | -1,388 | -437 | -5,340 |
| Capital Expenditure | -25 | -13 | -5 | N/A |
| Free Cash Flow | -2,087 | -1,401 | -442 | -5,340 |